Chapter 10 A Typology of Strategic Groups Within Biotechnology IPOs

Abstract

The strategic management literature has developed several typologies and taxonomies concerning large, established firms. Yet, to date, no study has attempted to classify newly formed organizations based on their strategic intent. The study of biotechnology firms undergoing an initial public offering presents a rare opportunity to study recently formed organizations within an emerging industry. Drawing from the strategic management and entrepreneurship literature, the present study offers a typology for these firms.

Citation

Williams, D.R. (2007), "Chapter 10 A Typology of Strategic Groups Within Biotechnology IPOs", Blair, J.D., Fottler, M.D., Ford, E.W. and Tyge Payne, G. (Ed.) Strategic Thinking and Entrepreneurial Action in the Health Care Industry (Advances in Health Care Management, Vol. 6), Emerald Group Publishing Limited, Leeds, pp. 239-255. https://doi.org/10.1016/S1474-8231(06)06010-1